Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 5, 2022, Dr. Raymond Schinazi informed the Board of Directors (the "Board") of Precision BioSciences, Inc. (the "Company" or "Precision") that he was resigning from the Board, as well as his roles as Chair of the Board's Nominating and Corporate Governance Committee and a member of the Board's Compensation Committee and Science and Technology Committee, with immediate effect. Dr. Schinazi will continue to serve on the Company's Scientific Advisory Board.

--------------------------------------------------------------------------------

Item 7.01. Regulation FD Disclosure

The Company issued a press release to announce the change to the Board. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated in this Item 7.01 by reference.

The information in this Item 7.01 (including Exhibit 99.1) of this Current Report on Form 8-K is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

--------------------------------------------------------------------------------

Item 9.01. Financial Statements and Exhibits.


  (d) Exhibits




Exhibit   Description
  No.

99.1        Press Release of Precision BioSciences, Inc., dated November 10, 2022

104       Cover Page Interactive Data File (embedded within the Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses